+ All Categories
Home > Documents > Antidiabetic study of combined extracts of Vernonia amygdalina, Ocimum gratissimum, and Gongronema...

Antidiabetic study of combined extracts of Vernonia amygdalina, Ocimum gratissimum, and Gongronema...

Date post: 16-Nov-2023
Category:
Upload: uniuyo
View: 0 times
Download: 0 times
Share this document with a friend
6
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/236153692 Antidiabetic study of combined extracts of Vernonia amygdalina, Ocimum gratissimum, and Gongronema latifolium on alloxaninduced diabetic rats ARTICLE · APRIL 2013 DOI: 10.4103/2229-5119.110345 CITATIONS 2 READS 553 4 AUTHORS, INCLUDING: Jude E Okokon University of Uyo 107 PUBLICATIONS 574 CITATIONS SEE PROFILE Available from: Jude E Okokon Retrieved on: 05 February 2016
Transcript

Seediscussions,stats,andauthorprofilesforthispublicationat:https://www.researchgate.net/publication/236153692

AntidiabeticstudyofcombinedextractsofVernoniaamygdalina,Ocimumgratissimum,andGongronemalatifoliumonalloxaninduceddiabeticrats

ARTICLE·APRIL2013

DOI:10.4103/2229-5119.110345

CITATIONS

2

READS

553

4AUTHORS,INCLUDING:

JudeEOkokon

UniversityofUyo

107PUBLICATIONS574CITATIONS

SEEPROFILE

Availablefrom:JudeEOkokon

Retrievedon:05February2016

Journal of Natural Pharmaceuticals, Volume 4, Issue 1, January-June, 201328

Address for correspondence:Dr. Jude E. Okokon,Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Uyo, Uyo, Nigeria.E-mail: judeefi [email protected]

Departments of Pharmacology and Toxicology,

1Pharmacognosy and Traditional Medicine, and

2Pharmaceutical and Medicinal Chemistry, Faculty of

Pharmacy, University of Uyo, Uyo, Nigeria

Antidiabetic study of combined extracts of Vernonia amygdalina, Ocimum gratissimum, and Gongronema latifolium on alloxan-induced diabetic rats

Jude E. Okokon, Uwemedimo F. Umoh1, Benjamin A. J. Ekpo1, Emmanuel I. Etim2

ABSTRACT

Introduction: Herbal products are often used as combinations of some herbs for the treatment of diseases in traditional medicine. The anti-diabetic activities of polyherbal combinations of Vernonia amygdalina (V. amygdalina), Gongronema latifolium (G. latifolium), and Ocimum gratissimum (O. gratissimum) used in folkloric management of diabetes. Materials and Methods: The various polyherbal combinations of V. amygdalina, G. latifolium, and O. gratissimum (100 mg/kg each) were evaluated for anti-diabetic activity in alloxan induced diabetic rats. The anti-diabetic activities during acute and prolonged studies were investigated. Glibenclamide, 10 mg/kg, was used as positive control. Blood glucose level (BGL) was measured at intervals by using glucometer. Results: Treatment of alloxan diabetic rats with the various herbal combinations caused signifi cant (P < 0.001) reductions in the BGL of the diabetic rats both in acute and prolonged treatment (2 weeks). The activities of various combined extracts were comparable and more pronounced than that of glibenclamide and compared to that of glibenclamide in the prolonged study. Conclusion: The anti-diabetic activities of the various herbal combinations confi rm the folkloric use of these polyherbal remedies.

Key words: Antidiabetic, Gongronema latifolium, Ocimum gratissimum, polyherbal, Vernonia amygdalina

Original Article

Access this article onlineAccess this article online

Website:Website: www.jnatpharm.orgDOI:DOI: 10.4103/2229-5119.110345

Quick Response Code:Quick Response Code:

INTRODUCTION

Ethnomedicine is an integral part of the culture of people of Akwa Ibom State[1] and about 75% of the people rely on traditional medicine for health-care delivery.[2] Majority of the people still patronize herbal remedies despite the availability of orthodox medicine in their management of some diseases and ailments. Besides, polyherbal therapy (practice) is a common practice in the Ibibio traditional medicine as combination of roots/leaves and stem barks of various plants are often use in the treatment of a single disease. Moreover, polyherbal therapy is said to be a current pharmacological principle having the advantage of producing maximum effi cacy with minimum side effects.[3] According to Tiwari and Rao,[4] polyherbal therapies have the synergy, potentiative, agonistic/antagonistic pharmacological agents within themselves, that work together in a dynamic way to produce therapeutic effi cacy with minimum side-effects. Diabetes is one of the diseases treated by herbalist of Ibibio tribe using polyherbal combinations.

Ethnobotanical information from some traditional medicine practioners revealed that Vernonia amygdalina (V. amygdalina), Ocimum gratissimum (O. gratissimum), and Gongronema latifolium (G. latifolium) constitute bulk of the many polyherbal combinations use in the area for the treatment of diabetes. Ajibesin et al.,[1] in their ethnobotanical survey of Akwa Ibom State documented the three plants as anti-diabetic remedies used in the region. Several workers have reported on the anti-diabetic/hypoglycemic activities V. amygdalina,[5-7] O. gratissimum,[6,8-10] and G. latifolium.[6,11-13] In this study, we investigated the effi cacy of the different combinations of the three plants on alloxan induced diabetic rats as used in ethnomedical therapy of diabetes in Akwa Ibom State to ascertain their potency.

MATERIALS AND METHODS

Plant materialsFresh leaves of V. amygdalina Del. (compositae), O. gratissimum Linn. (Labiaceace), and G. latifolium Benth.

Okokon, et al.: Antidiabetic activities of polyherbal combinations on diabetic rats

Journal of Natural Pharmaceuticals, Volume 4, Issue 1, January-June, 2013 29

(Asclapiadaceace) were collected in August, 2008 from the Medicinal plants farm of Faculty of Pharmacy, University of Uyo, Uyo, Nigeria. The plant was identifi ed and authenticated by Dr. Margaret Bassey, a taxonomist in the Department of Botany, University of Uyo, Uyo, Nigeria.

ExtractionThe fresh leaves (2 kg) of each plant were air-dried separately on laboratory table for 2 weeks and reduced to powder. The powder (100 g) of each plant was macerated in 95% ethanol (300 mL) for 72 h (cold extraction). The liquid fi ltrates obtained were concentrated in vacuo at 40°C. The extracts were stored in a refrigerator at 4°C until used for experiment reported in this study.

AnimalsAlbino Wistar rats (155-165 g) of either sex were obtained from the University of Uyo animal house. They were maintained on standard animal pellets (Guinea Feed) and water ad libitum. Permission and approval for animal studies were obtained from the College of Health Sciences Animal Ethics Committee, University of Uyo.

Induction of diabetesThe animals were fasted overnight and diabetes was induced by a single intraperitoneal injection of a freshly prepared solution of alloxan (150 mg/kg body weight) in ice cold 0.9% sodium chloride (NaCl) saline solution. The animals were allowed to drink 5% glucose solution overnight to overcome the drug-induced hypoglycemia. Control rats were injected with normal saline alone. After 72 h for the development of diabetes, rats with moderate diabetes having glycosuria and hyperglycemia (blood glucose level (BGL) range above 200 mg/dl) were considered as diabetic and used for the drug treatment. The leaf extracts of the three plants in aqueous solution were administered to rats orally through a gavage at a concentration of 100 mg/kg body weight/rats/day for 14 days.

Experimental designThe animals were divided into six groups of six rats each and treated as follows:• Group I: Diabetic rats administered orally with

combined leaf extracts of G. latifolium, V. amygdalina, and O. gratissimum (GVOE) at a dose of 100 mg/kg/day each extract in aqueous solution for 14 days.

• Group II: Diabetic rats given leaf extracts of O. gratissimum and G. latifolium (OGE) at a dose of 100 mg/kg/day in aqueous solution orally for 14 days.

• Group III: Diabetic rats administered orally with leaf extracts of G. latifolium and V. amygdalina (GVE) at a dose of 100 mg/kg/day each extract in aqueous solution for 14 days.

• Group IV: Diabetic rats administered orally with leaf extract of O. gratissimum and V. amygdalina (OVE) at a dose of 100 mg/kg/day each extract in aqueous solution for 14 days.

• Group V: Diabetic rats given glibenclamide (10 mg/kg/day) for 14 days in aqueous solution orally for 14 days.

• Group VI: Diabetic control rats.

The fasting BGLs of all the rats were recorded at regular intervals during the experimental period. For acute study, the BGL was monitored after 1, 3, 5, and 7 h of administration of a single dose of the extract and at the end of 1, 3, 5, 7, 10, 12, and 14 days for prolonged treatments. The BGL was monitored in the blood of the diabetic rats by tail tipping method. The blood was dropped on the dextrostix reagent pad and was inserted into microprocessor digital blood glucometer and the readings were noted.[14]

Statistical analysisData are reported as mean ± standard error of the mean (SEM) and were analyzed statistically using one-way analysis of variance followed by Tukey–Kramer multiple comparison test and values of P < 0.001 and 0.05 were considered signifi cant.[15]

RESULTS

During acute study of the effects of the combined extracts on BGL of the diabetic rats, all the groups treated with combined leaf extracts exhibited signifi cant (P < 0.001) reductions in BGL compared to control and the effects were more pronounced than those of the group treated with glibenclamide (10 mg/kg). Though, all the combined extracts-treated groups had comparable activities, the group treated with the combined leaf OGE had the most signifi cant reduction after 7 h (80.97%,7 h), followed by those treated with GVE (79.21%, 7 h), GVOE (76.93%, 7 h), and OVE (74.90%,7 h) [Table 1].

During prolonged study, the combined extracts-treated groups and glibenclamide treated group produced sustained signifi cant (P < 0.001) reduction in BGL of the diabetic compared to control [Table 2]. The effect of the combined extracts and that of glibenclamide were comparable on day 15. A more pronounced effect was observed in the group treated with a combined extracts of the three plants, i.e., GVOE.

DISCUSSION

The anti-diabetic effects of different combinations of leaf extracts of G. latifolium, V. amygdalina and O. gratissimum use in polyherbal therapy of diabetes

Okokon, et al.: Antidiabetic activities of polyherbal combinations on diabetic rats

Journal of Natural Pharmaceuticals, Volume 4, Issue 1, January-June, 201330

were evaluated in this study. The results showed that the various combinations: G. latifolium and O. gratissimum; G. latifolium and V. amygdalina; G. latifolium, V. amygdalina, and O. gratissimum; and O. gratissimum and V. amygdalina, had signifi cant antihyperglycemic activity which was more than that of glibenclamide (in acute study) and comparable in effect to glibenclamide (during prolonged study). Within the treatment period (14 days) the various combined extracts’ effects demonstrated synergism as the extracts appeared to complement each other thereby reducing the BGL of the diabetic rats to normal. This was clearly demonstrated in the group administered combination of the three extracts during prolonged study. The results of this study collaborates the advantages of polyherbal articulated by Tiwari and Rao.[4] Furthermore, the results of this study support earlier reports of anti-diabetic potentials of these plants.[5-10] Different mechanism of actions of anti-diabetic plants have been proposed such as potentiation of insulin effect either by increasing the pancreatic secretion of insulin from the cells of islets of Langerhans or its release from bound insulin,[16] inhibition of hepatic glucose production,[17] inhibition of intestinal glucose absorption,[18] or correction of insulin resistance.[19] These three extracts may have exerted their anti-diabetic effects by utilizing one or more of the above mechanisms. A combination of these mechanisms could have resulted in the signifi cant anti-diabetic activity

observed in this study, which is likely to be sustained and better than that of a single extract. Moreover, sulfonyl ureas, including glibenclamide, produce hypoglycemia in normal as well as diabetic animals by stimulating the pancreatic -cells to release more insulin.[20] These extracts’ combinations maybe working through a similar mechanism like glibenclamide as the results gotten from the combinations and glibenclamide were comparable. Secondary metabolites have been reported to be involved in anti-diabetic activity of many plants.[21] Reports have shown that these plants have various phytochemical constituents in common such as alkaloids, steroids, glycosides, saponins, tannins, terpenes, and fl avonoids.[8,22,23] In addition to anti-diabetic properties of these plants, each of the plants has been reported of different activities geared towards alleviation of complications usually associated with diabetes. For example, V. amygdalina has been reported to be hepatoprotective[24] and antioxidant,[25] G. latifolium, antioxidant, hepatoprotective and hypolipidaemic,[11,26] O. gratissimum, antioxidant[27] and others. All these activities complements the anti-diabetic activities of these plants and are advantageous to antagonize and resolve any side effects any of the extracts could have posed. The effectiveness of polyherbal combination has been reported widely. V. amygdalina and Azadirachta indica combination has been shown to be very effective.[3]

Table 1: Eff ect of polyherbal combinati ons on blood glucose levels of alloxan diabeti c rats aft er a single dose

Drug Dose (mg/kg) Blood glucose level (mg/dl) (mean±SEM)

Ini al 1 h 3 h 5 h 7 h

Control 240.3 ± 1.05 245.2 ± 1.39 262.9 ± 0.75 264.7 ± 0.95 266.2 ± 0.95Extracts

GVOE 100/extract 247.0 ± 2.83 216.6 ± 2.13* 150.0 ± 3.32* 91.0 ± 2.00* 57.0 ± 2.24*OGE 100/extract 260.0 ± 2.86 167.5 ± 1.30* 164.0 ± 3.65* 67.0 ± 1.09* 49.5 ± 1.59*GVE 100/extract 252.5 ± 2.50 105.0 ± 2.20 100.5 ± 2.23 78.5 ± 2.65* 52.5 ± 1.45*OVE 100/extract 247.0 ± 0.24 149.0 ± 3.28* 112.0 ± 1.36* 69.3 ± 2.25* 62.0 ± 1.11*Glibenclamide 10 243.8 ± 1.42 169.4 ± 2.38* 162.4 ± 2.11* 148.2 ± 0.51* 130.3 ± 0.75*

*P<0.001 when compared to control. n=6 per group. GVOE: Gongronema la folium, Vernonia amygdalina and Ocimum gra ssimum combined extracts, OGE: Ocimum gra ssimum and Gongronema la folium combined extracts, GVE: Gongronema la folium and Vernonia amygdalina combined extracts, OVE: Ocimum gra ssimum and Vernonia amygdalina combined extracts, SEM: Standard error of the mean

Table 2: Eff ect of polyherbal combinati ons on blood glucose levels of alloxan diabeti c rats during prolonged treatment

Treatment Dose (mg/kg) Blood glucose level (mg/dl) (mean±SEM)

Ini al 1st day 3rd day 5th day 7th day 10th day 12th day 15th day

Control 240.0 ± 1.05 245.2 ± 1.39 260.1 ± 1.51 263.2 ± 0.98 265.2 ± 1.92 265.3 ± 1.26 268.7 ± 1.34 270.2 ± 0.82Extracts

GVOE 100/extract 247.0 ± 2.83 162.0 ± 1.27* 86.0 ± 2.00* 78.3 ± 1.19* 72.6 ± 1.26* 61.8 ± 1.47* 51.5 ± 1.53* 51.0 ± 1.83*OGE 100/extract 260.0 ± 2.86 175.5 ± 1.75* 85.0 ± 1.73* 76.8 ± 1.90* 71.0 ± 1.15* 66.5 ± 1.50* 63.4 ± 1.53* 56.3 ± 2.41*GVE 100/extract 252.5 ± 2.50 186.5 ± 2.91* 92.3 ± 1.08* 86.5 ± 1.54* 81.2 ± 1.59* 74.4 ± 1.15* 63.8 ± 1.03* 53.2 ± 2.14*OVE 100/extract 247.0 ± 0.24 154.0 ± 1.12* 91.4 ± 1.44* 89.7 ± 1.64* 77.5 ± 1.12* 68.8 ± 2.42* 62.5 ± 2.91* 57.9 ± 1.36*Glibenclamide 10 243.8 ± 1.42 13.1 ± 2.28* 78.2 ± 1.26* 73.8 ± 1.43* 67.6 ± 1.12* 65.4 ± 1.33* 60.3 ± 3.11* 55.4 ± 1.25*

*P<0.001 when compared to control, n=6 per group. GVOE: Gongronema la folium, Vernonia amygdalina and Ocimum gra ssimum combined extracts, OGE: Ocimum gra ssimum and Gongronema la folium combined extracts, GVE: Gongronema la folium and Vernonia amygdalina combined extracts, OVE: Ocimum gra ssimum and Vernonia amygdalina combined extracts, SEM: Standard error of the mean

Okokon, et al.: Antidiabetic activities of polyherbal combinations on diabetic rats

Journal of Natural Pharmaceuticals, Volume 4, Issue 1, January-June, 2013 31

CONCLUSION

The fi nding of this study confi rms the effi cacy of the various polyherbal combinations used traditionally by herbalists of Ibibio tribe of Akwa Ibom State, Nigeria for the management of diabetes which are of advantage. Further studies into polyherbal combinations used in the management of diabetes are encouraged to support the advantage of polytherapy.

ACKNOWLEDGMENT

The authors are grateful to Mr. Nsikan Malachy of Pharmacology and Toxicology Department, University of Uyo, Uyo, N igeria for his technical assistance.

REFERENCES

1. Ajibesin KK, Ekpo BA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of Akwa Ibom State of Nigeria. J Ethnopharmacol 2008;115:387-408.

2. Etukudo I. Ethnobotany: Conventional and Traditional Uses of Plants. Nigeria: The Verdict Press; 2003. p. 156-80.

3. Ebong PE, Atangwho IJ, Eyong EU, Egbung GE. The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica (A. Juss) (Neem) and Vernonia amygdalina (Del.) (African bitter leaf). Am J Biochem Biotechnol 2008;4:239-44.

4. Tiwari AK, Rao JM. Diabetes mellitus and multiple approaches of phytochemicals: Present status and future prospects. Curr Sci 2002;83:30-7.

5. Osinubi AA. Effects of Vernonia amygdalina and chlorpropamide on blood glucose. Med J Islam World Acad Sci 2004;16:115-9.

6. Ogundipe OO, Moody J, Akinyemi TO, Raman A. Hypoglycaemic potentials of methanolic extracts of selected foods in alloxanised mice. J Plant Food Human Nutr 2005;58:1-7.

7. Akah PA, Okafor CI. Hypoglycaemic effect of Vernonia amygdalina Del. in experimental rabbits. Plant Med Res 1992;1:6-10.

8. Mohammed A, Tanko Y, Okasha M, Magaji RA, Yaro AH. Effects of aqueous leaves extract of Ocimum gratissimum on blood glucose levels of streptozotocin-induced diabetic wistar rats. Afr J Biotechnol 2007;6:2087-90.

9. Egesie UG, Adelaiye AB, Ibu JO, Egesie OJ. Safety and hypoglycaemic properties of aqueous leaf extract of Ocimum gratissimum in streptozotocin induced diabetic rats. Niger J Physiol Sci 2006;21:31-5.

10. Aguiyi JC, Obi CI, Gang SS, Igweh AC. Hypoglycaemic activity of Ocimum gratissimum in rats. Fitoterapia 2000;71:444-6.

11. Ugochukwu NH, Babady NE, Cobourne M, Gasset SR. The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats. J Biosci 2003;28:1-5.

12. Nwanjo HU. Effect of aqueous extract of Gongronema latifolium leaf on blood glucose level in rats. Alvan J Sci 2007;1:84-9.

13. Ugochukwu NH, Babady NE. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci 2003;73:1925-38.

14. WHO expert committee on diabetes mellitus. Tech. Rep. Series No. 646. Geneva: World Health Organisation; 1980. p. 9-14.

15. Davis SN. Insulin, oral hypoglycaemic agent and the pharmacology of the endocrine pancreas. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006. p. 1613-88.

16. Pari L, Amarnath Satheesh M. Antidiabetic activity of Boerhaavia diffusa L.: Effect on hepatic key enzymes in experimental diabetes. J Ethnopharmacol 2004;91:109-13.

17. Eddouks M, Jouad H, Maghrani M, Lemhadri A, Burcelin R. Inhibition of endogenous glucose production accounts for hypoglycemic effect of Spergularia purpurea in streptozotocin mice. Phytomedicine 2003;10:594-9.

18. Youn JY, Park HY, Cho KH. Anti-hyperglycemic activity of Commelina communis L.: Inhibition of alpha-glucosidase. Diabetes Res Clin Pract 2004;66:S149-55.

19. Hu X, Sato J, Oshida Y, Xu M, Bajotto G, Sato Y. Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2003;59:103-11.

20. Akpan MM, Okokon JE, Akpan EJ. Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Carpolobia lutea. Mol Clin Pharmacol 2012;3:100-7.

21. Kako M, Miura T, Nishiyama Y, Ichimaru M, Moriyasu M, Kato A. Hypoglycemic activity of some triterpenoid glycosides. J Nat Prod 1997;60:604-5.

22. Nwanjo HU, Okafor MC, Oze GO. Anti-lipid peroxidative activity of Gongronema latifolium in streptozotocin-induced diabetic rats. Niger J Physiol Sci 2006;21:61-5.

23. Eteng MU, Bassey BJ, Atangwho GE, Egbung GE, Eyong EU, Ebong PE, et al. Biochemical indices of macrovascular complication in diabetic rat model: Compared effects of Vernonia amygdalina, Catharantus roseus and chlorpropamide. Asian J Biochem 2008;3:228-34.

24. Kim JS, Ju JB, Choi CW, Kim SC. Hypoglycaemic and antihyperglycaemic effect of four Korean medicinal plants in alloxan induced diabetic rats. Am J Biochem Biotechnol 2006; 2:154-60.

25. Igile GO, Oleszek W, Jurzysta M, Burda S, Fafunso M, Fasanmade AA. Flavonoids from Vernonia amygdalina and their antioxidant activities. J Agric Food Chem 1994;42:2445-8.

26. Nwanjo HU, Alumanah EO. Effect of aqueous extract of Gongronema latifolium leaf on some indices of liver function in rats. Glob J Med Sci 2006;4:29-32.

27. Seung-Joo-Lee KU, Takayuki S, Kwang-Guen L. Identification of violatile components in basil (Ocimum basilicum) and thyme leaves (Thymus vulgaris) and their antioxidant properties. Food Chem 2004;91:131-7.

Cite this article as: Okokon JE, Umoh UF, Ekpo BA, Etim EI. Antidiabetic study of combined extracts of Vernonia amygdalina, Ocimum gratissimum, and Gongronema latifolium on alloxan-induced diabetic rats. J Nat Pharm 2013;4:28-31.

Source of Support: Nil. Confl ict of Interest: No.


Recommended